Intraocular Pressure in Ocular Hypertensives With Scleral Lens Wear
NCT ID: NCT04442464
Last Updated: 2024-04-29
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
1 participants
INTERVENTIONAL
2020-07-01
2020-08-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Posterior Scleral Reinforcement on Controlling Myopia in Adults With High Myopia
NCT03381079
Long-term Effects of Laser Refractive Surgery
NCT00350246
Myopia Control Spectacle Lens Cessation Study
NCT05893979
The Effect of a Scleral Lens on the Anterior Chamber Depth and Minimum Rim Width
NCT03926975
Corneal Biomechanics Study
NCT03658239
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study Eye
One eye will be randomly selected to wear the scleral lenses to be worn during study measurements
Scleral Lens
15.0 mm diagnostic spherical rigid contact lens
Control Eye
Non-lens wearing eye
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Scleral Lens
15.0 mm diagnostic spherical rigid contact lens
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* May have had cataract extraction and intraocular lens (IOL)
* Not on topical medication for glaucoma
* No History of ALT/SLT
* Any Age, 18 years or older
* History of contact lens wear (except scleral lenses), as long as they are willing to not wear their lenses the day of the study
Exclusion Criteria
* Eye disease
* Inability to wear scleral lenses
* Any intraocular surgery other than uncomplicated cataract extraction.
* Known allergy to proparacaine eye drops
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cherie B. Nau
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cherie Nau, OD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-004974
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.